General Information
Revision date
2024-12-16
Product name
NALIDIXIC ACID SELECTIVE SUPPLEMENT
Product name
NALIDIXIC ACID SELECTIVE SUPPLEMENT
Identification on the label/Trade name
Biolife Italiana S.r.l
CAS No.
3374-05-8
1.2.1 Relevant identified uses
Laboratory chemical product. Culture medium for microbiology
Emergency telephone
0845 4647
Icons in SDS
Company Information
company name
Biolife Italiana S.r.l
e-mail address of the competent person responsible for the Safety Data Sheet
mktg@biolifeitaliana.it
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H317, H334
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Hazard labelling pursuant to EC Regulation 1272/2008 (CLP) and subsequent amendments and supplements. Classification of the substance or mixture
Signal word
Danger
Hazard statements
H302 Harmful if swallowed. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H317 May cause an allergic skin reaction.
Precautionary statements
P261 Avoid breathing dust / fume / gas / mist / vapours / spray. P280 Wear protective gloves. P342+P311 If experiencing respiratory symptoms: Call a POISON CENTER / doctor / . . . P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P333+P313 If skin irritation or rash occurs: Get medical advice / attention. P264 Wash . . . thoroughly after handling.
Contains
NALIDIXIC ACID SODIUM SALT Nr. EC: 222-159-7
2.3 Other hazards
The substance does not have persistence, bioaccumulation and toxicity (PBT) properties and is not very persistent and very bioaccumulative. (vPvB). The substance does not have endocrine disrupting properties.
2.1 Classification of the substance or mixture
The product is classified as hazardous pursuant to the provisions set forth in (EC) Regulation 1272/2008 (CLP) (and subsequent amendments and supplements). The product thus requires a safety datasheet that complies with the provisions of (EU) Regulation 2020/878. Any additional information concerning the risks for health and/or the environment are given in sections 11 and 12 of this sheet. Hazard classification and indication: Acute toxicity, category 4 H302 Harmful if swallowed. Respiratory sensitization, category 1 H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. Skin sensitization, category 1 H317 May cause an allergic skin reaction.